NCT04164199 Study of Tislelizumab, Pamiparib, and Other Investigational Agents in Participants With Advanced Malignancies Status COMPLETED Phase PHASE3
NCT03967977 Study of Tislelizumab in Combination With Chemotherapy Compared to Chemotherapy Alone for Participants With Urothelial Carcinoma Status ACTIVE_NOT_RECRUITING Phase PHASE3